Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes

Detalles Bibliográficos
Autores principales: Sugimoto, Masahiko, Handa, Chiharu, Hirano, Kazufumi, Sunaya, Toshiyuki, Kondo, Mineo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803755/
https://www.ncbi.nlm.nih.gov/pubmed/36472690
http://dx.doi.org/10.1007/s00417-022-05917-x
_version_ 1784861953540227072
author Sugimoto, Masahiko
Handa, Chiharu
Hirano, Kazufumi
Sunaya, Toshiyuki
Kondo, Mineo
author_facet Sugimoto, Masahiko
Handa, Chiharu
Hirano, Kazufumi
Sunaya, Toshiyuki
Kondo, Mineo
author_sort Sugimoto, Masahiko
collection PubMed
description
format Online
Article
Text
id pubmed-9803755
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98037552023-01-01 Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes Sugimoto, Masahiko Handa, Chiharu Hirano, Kazufumi Sunaya, Toshiyuki Kondo, Mineo Graefes Arch Clin Exp Ophthalmol Correction Springer Berlin Heidelberg 2022-12-06 2023 /pmc/articles/PMC9803755/ /pubmed/36472690 http://dx.doi.org/10.1007/s00417-022-05917-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Sugimoto, Masahiko
Handa, Chiharu
Hirano, Kazufumi
Sunaya, Toshiyuki
Kondo, Mineo
Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes
title Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes
title_full Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes
title_fullStr Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes
title_full_unstemmed Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes
title_short Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes
title_sort correction to: intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in japan: 24‑month outcomes
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803755/
https://www.ncbi.nlm.nih.gov/pubmed/36472690
http://dx.doi.org/10.1007/s00417-022-05917-x
work_keys_str_mv AT sugimotomasahiko correctiontointravitrealafliberceptfordiabeticmacularedemainrealworldclinicalpracticeinjapan24monthoutcomes
AT handachiharu correctiontointravitrealafliberceptfordiabeticmacularedemainrealworldclinicalpracticeinjapan24monthoutcomes
AT hiranokazufumi correctiontointravitrealafliberceptfordiabeticmacularedemainrealworldclinicalpracticeinjapan24monthoutcomes
AT sunayatoshiyuki correctiontointravitrealafliberceptfordiabeticmacularedemainrealworldclinicalpracticeinjapan24monthoutcomes
AT kondomineo correctiontointravitrealafliberceptfordiabeticmacularedemainrealworldclinicalpracticeinjapan24monthoutcomes

Ejemplares similares